Proteon Therapeutics Inc. Secures $38,000,000 Series B Financing
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=59912525-3ffa-4b5e-a87d-a1498c36cbe1&Preview=1
Date 3/5/2009
Company Name Proteon Therapeutics Inc.
Mailing Address 200 West Street Waltham, MA 02451
Company Description Proteon Therapeutics is a biopharmaceutical company developing PRT-201, a novel human recombinant protein that permanently dilates segments of blood vessels, blocks vasospasm, and reduces the formation of vascular scarring.